ÂÜÀòÂÒÂ×

FL

F. Stephen Laroux

Director, Inflammatory Diseases & Immunology at ViThera Pharma

Dr. Laroux is Director, Inflammatory Diseases and Immunology at ViThera. Most recently, Dr. Laroux was Director of Immunology and Inflammatory Diseases at Cequent Pharmaceuticals, where he directed the preclinical discovery efforts and large-pharma collaborations based on the tkRNAi platform.Dr. Laroux completed a post-doctoral fellowship at Beth Israel Deaconess Medical Center, Harvard Medical School where he conducted research focused on innate immune responses to bacteria as well as the role of the immune system in chronic disease. Prior to his tenure at BIDMC, Dr. Laroux conducted research into the immunology of diseases such as IBD, rheumatoid arthritis, ischemia-reperfusion and myocardial infarction, co-authoring over 40 publications in peer-reviewed journals. Dr. Laroux received his Master's degree in Human Physiology in 2000 and his Ph.D. (Chancellor's Award) in Molecular and Cellular Physiology in 2003 both from Louisiana State University.